Qantas Leads ASX 200 Gainers as Telix Stumbles on Supply Chain Issues

2 min read | August 27, 2025 10:29 PM PDT | By Team Kalkine Media

Qantas Leads ASX 200 Gainers as Telix Stumbles on Supply Chain Issues — Image source: Pexels

Telix Pharmaceuticals Declines Following Regulatory Notification

Telix Pharmaceuticals Ltd (ASX:TLX) experienced a significant decline after disclosing that the US Food and Drug Administration flagged concerns around the company’s supply chain processes for one of its novel imaging agents. The update weighed on market sentiment, impacting TLX’s early performance despite broader stability in healthcare shares.

This development underscored the sensitivity of pharmaceutical stocks to regulatory feedback, especially those operating in niche sectors with complex manufacturing and compliance processes.

Mixed Reactions to Earnings as Key Stocks Post Gains and Losses

Outside of Qantas and Telix, earnings reports from several major ASX-listed companies triggered notable market responses. Macquarie Technology Group Ltd (ASX:MAQ), Ramsay Health Care Ltd (ASX:RHC), and IGO Ltd (ASX:IGO) all declined in early trade. These movements followed the release of financial results that diverged from market expectations.

Meanwhile, investor attention remained focused on key names including Wesfarmers Ltd (ASX:WES), Medibank Private Ltd (ASX:MPL), and TPG Telecom Ltd (ASX:TPG), which were also expected to report earnings during the session.

Uranium and Gold Miners Remain on Watch

Following recent momentum in the resources space, market watchers continued to track stocks such as Perseus Mining Ltd (ASX:PRU) and South32 Ltd (ASX:S32). While broader commodity trends showed some easing, pockets of strength in mining and energy stocks provided a backdrop of resilience across select sub-sectors.

With earnings season underway, further movement is anticipated across sectors as financial disclosures and company-specific updates shape trading activity in the coming days.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media LLC (Kalkine Media, we or us) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.